Efficacy and safety of carboplatin and etoposide in older extensive‐stage small‐cell lung cancer patients with a poor performance status

Carboplatin plus etoposide is a standard treatment for older extensive‐stage small‐cell lung cancer (ES‐SCLC) patients with performance status (PS) 2. However, older patients often exhibit poor PS (3, 4), and the treatment effect in them is poorly understood. To determine the therapeutic efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mamesaya, Nobuaki, Kodama, Hiroaki, Iida, Yuko, Kobayashi, Haruki, Ko, Ryo, Wakuda, Kazushige, Ono, Akira, Kenmotsu, Hirotsugu, Naito, Tateaki, Murakami, Haruyasu, Shimizu, Tetsuo, Gon, Yasuhiro, Takahashi, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040279/
https://www.ncbi.nlm.nih.gov/pubmed/36700290
http://dx.doi.org/10.1111/1759-7714.14811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040279/
https://www.ncbi.nlm.nih.gov/pubmed/36700290
http://dx.doi.org/10.1111/1759-7714.14811

Ejemplares similares